go back

Louisiana rates for HCPCS Q0173

Trimethobenzamide HCl, 250 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Facilitymedian $1 · 10th–90th $1$10%50%$1Professionalmedian $1 · 10th–90th $1$10%50%10th90th$1$0.5$1.0$2.0$5.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1.95
Median
$7.94
Typical High
$7.94
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.91
Median
$0.91
Typical High
$0.91
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.91
Median
$0.91
Typical High
$0.91
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.83
Median
$0.95
Typical High
$1.70
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.83
Median
$0.83
Typical High
$0.83
United
Setting
Facility
Modifier
Global
Typical Low
$0.55
Median
$0.65
Typical High
$0.79
United
Setting
Professional
Modifier
Global
Typical Low
$0.71
Median
$0.83
Typical High
$0.87